Eiko Lifesciences Ltd — Updates, 14-05-2025: Company Update

Eiko LifeSciences Limited has announced a board meeting to approve its audited standalone and consolidated financial results for the quarter and year ended March 31, 2025. The company reported consolidated revenue of INR 37.66 Cr and a profit before tax of INR 3.06 Cr for the year, with a basic EPS of ₹1.62. The standalone business showed revenue of INR 32.49 Cr and a profit after tax of INR 1.74 Cr. Exceptional income includes interest from delayed rights share payments. PSV Jain & Associates issued an unmodified audit opinion. The company appointed Shravan Gupta & Associates as Secretarial Auditor for five years and NP Rajput & Co. as Internal Auditor for FY 2025-26, both subject to shareholder approval.